546
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Effects of current smoking severity on brain gray matter volume in opioid use disorder – a voxel-based morphometry study

ORCID Icon, , , , , , , & show all
Pages 180-189 | Received 18 Aug 2022, Accepted 13 Jan 2023, Published online: 14 Feb 2023

References

  • Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, Marshall BDL, Tyndall M, Walsh SL. Opioid use disorder. Nat Rev Dis Primers. 2020;6:3. doi:10.1038/s41572-019-0137-5.
  • John WS, Zhu H, Mannelli P, Subramaniam GA, Schwartz RP, McNeely J, Wu L-T. Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco. Drug Alcohol Depend. 2019;194:468–75. doi:10.1016/j.drugalcdep.2018.11.011.
  • Rajabi A, Dehghani M, Shojaei A, Farjam M, Motevalian SA. Association between tobacco smoking and opioid use: a meta-analysis. Addict Behav. 2019;92:225–35. doi:10.1016/j.addbeh.2018.11.043.
  • Parker MA, Weinberger AH, Villanti AC. Quit ratios for cigarette smoking among individuals with opioid misuse and opioid use disorder in the United States. Drug Alcohol Depend. 2020;214:108164. doi:10.1016/j.drugalcdep.2020.108164.
  • Solis E Jr., Cameron-Burr KT, Shaham Y, Kiyatkin EA. Intravenous heroin induces rapid brain hypoxia and hyperglycemia that precede brain metabolic response. eNeuro. 2017;4. doi:10.1523/ENEURO.0151-17.2017.
  • Murray DE, Durazzo TC, Schmidt TP, Murray TA, Abe C, Guydish J, Meyerhoff DJ. Regional cerebral blood flow in opiate dependence relates to substance use and neuropsychological performance. Addict Biol. 2018;23:781–95. doi:10.1111/adb.12523.
  • Zonneveld HI, Loehrer EA, Hofman A, Niessen WJ, van der Lugt A, Krestin GP, Ikram MA, Vernooij MW. The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population. J Cereb Blood Flow Metab. 2015;35:1882–87. doi:10.1038/jcbfm.2015.157.
  • Wollman SC, Alhassoon OM, Hall MG, Stern MJ, Connors EJ, Kimmel CL, Allen KE, Stephan RA, Radua J. Gray matter abnormalities in opioid-dependent patients: a neuroimaging meta-analysis. Am J Drug Alcohol Abuse. 2017;43:505–17. doi:10.1080/00952990.2016.1245312.
  • Liu J, Liang J, Qin W, Tian J, Yuan K, Bai L, Zhang Y, Wang W, Wang Y, Li Q, et al. Dysfunctional connectivity patterns in chronic heroin users: an fMRI study. Neurosci Lett. 2009;460:72–77. doi:10.1016/j.neulet.2009.05.038.
  • Upadhyay J, Maleki N, Potter J, Elman I, Rudrauf D, Knudsen J, Wallin D, Pendse G, McDonald L, Griffin M, et al. Alterations in brain structure and functional connectivity in prescription opioid-dependent patients. Brain. 2010;133:2098–114. doi:10.1093/brain/awq138.
  • Qiu YW, Jiang GH, Su HH, Lv XF, Tian JZ, Li LM, Zhuo F-Z. The impulsivity behavior is correlated with prefrontal cortex gray matter volume reduction in heroin-dependent individuals. Neurosci Lett. 2013;538:43–48. doi:10.1016/j.neulet.2013.01.019.
  • Bach P, Frischknecht U, Reinhard I, Bekier N, Demirakca T, Ende G, Vollstädt-Klein S, Kiefer F, Hermann D. Impaired working memory performance in opioid-dependent patients is related to reduced insula gray matter volume: a voxel-based morphometric study. Eur Arch Psychiatry Clin Neurosci. 2021;271:813–22. doi:10.1007/s00406-019-01052-7.
  • Shi Z, Langleben DD, O’Brien CP, Childress AR, Wiers CE. Multivariate pattern analysis links drug use severity to distributed cortical hypoactivity during emotional inhibitory control in opioid use disorder. Neuroimage Clin. 2021;32:102806. doi:10.1016/j.nicl.2021.102806.
  • Arias F, Arnsten JH, Cunningham CO, Coulehan K, Batchelder A, Brisbane M, Segal K, Rivera-Mindt M. Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults. Addict Behav. 2016;60:137–43. doi:10.1016/j.addbeh.2016.03.018.
  • Gray JC, Thompson M, Bachman C, Owens MM, Murphy M, Palmer R. Associations of cigarette smoking with gray and white matter in the UK Biobank. Neuropsychopharmacology. 2020;45:1215–22. doi:10.1038/s41386-020-0630-2.
  • Brody AL, Mandelkern MA, Jarvik ME, Lee GS, Smith EC, Huang JC, Bota RG, Bartzokis G, London ED. Differences between smokers and nonsmokers in regional gray matter volumes and densities. Biol Psychiatry. 2004;55:77–84. doi:10.1016/S0006-3223(03)00610-3.
  • Franklin TR, Wetherill RR, Jagannathan K, Johnson B, Mumma J, Hager N, Rao H, Childress AR. The effects of chronic cigarette smoking on gray matter volume: influence of sex. PLoS One. 2014;9(8):e104102. doi:10.1371/journal.pone.0104102.
  • Yu R, Zhao L, Lu L. Regional grey and white matter changes in heavy male smokers. PLoS One. 2011;6:e27440. doi:10.1371/journal.pone.0027440.
  • Elbejjani M, Auer R, Jacobs DR Jr., Haight T, Davatzikos C, Goff DC Jr., Bryan RN, Launer LJ. Cigarette smoking and gray matter brain volumes in middle age adults: the CARDIA Brain MRI sub-study. Transl Psychiatry. 2019;9:78. doi:10.1038/s41398-019-0401-1.
  • Wang AL, Shi Z, Elman I, Langleben DD. Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder. Am J Drug Alcohol Abuse. 2020;46:472–77. doi:10.1080/00952990.2020.1741001.
  • Wang AL, Shi Z, Fairchild VP, Aronowitz CA, Langleben DD. Emotional salience of the image component facilitates recall of the text of cigarette warning labels. Eur J Public Health. 2019;29:153–58. doi:10.1093/eurpub/cky059.
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatr. 1998;59:22–33; quiz 4-57.
  • Kosten TA, Rounsaville BJ. Sensitivity of psychiatric diagnosis based on the best estimate procedure. Am J Psychiatry. 1992;149:1225–27.
  • Harris KJ, Golbeck AL, Cronk NJ, Catley D, Conway K, Williams KB. Timeline follow-back versus global self-reports of tobacco smoking: a comparison of findings with nondaily smokers. Psychol Addict Behav. 2009;23:368–72. doi:10.1037/a0015270.
  • Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage. 2007;38:95–113. doi:10.1016/j.neuroimage.2007.07.007.
  • Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, Allen NB, Alia-Klein N, Batalla A, Blaine S, et al. Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am J Psychiatry. 2019;176:119–28. doi:10.1176/appi.ajp.2018.17040415.
  • Nader DA, Sanchez ZM. Effects of regular cannabis use on neurocognition, brain structure, and function: a systematic review of findings in adults. Am J Drug Alcohol Abuse. 2018;44:4–18. doi:10.1080/00952990.2017.1306746.
  • Wollman SC, Hauson AO, Hall MG, Connors EJ, Allen KE, Stern MJ, Stephan RA, Kimmel CL, Sarkissians S, Barlet BD, et al. Neuropsychological functioning in opioid use disorder: a research synthesis and meta-analysis. Am J Drug Alcohol Abuse. 2019;45:11–25. doi:10.1080/00952990.2018.1517262.
  • Whitwell JL. Voxel-based morphometry: an automated technique for assessing structural changes in the brain. J Neurosci. 2009;29:9661–64. doi:10.1523/JNEUROSCI.2160-09.2009.
  • Yuan P, Raz N. Prefrontal cortex and executive functions in healthy adults: a meta-analysis of structural neuroimaging studies. Neurosci Biobehav Rev. 2014;42:180–92. doi:10.1016/j.neubiorev.2014.02.005.
  • Palffy Z, Farkas K, Csukly G, Keri S, Polner B. Cross-modal auditory priors drive the perception of bistable visual stimuli with reliable differences between individuals. Sci Rep. 2021;11:16943. doi:10.1038/s41598-021-96198-7.
  • Lubman DI, Peters LA, Mogg K, Bradley BP, Deakin JF. Attentional bias for drug cues in opiate dependence. Psychol Med. 2000;30:169–75. doi:10.1017/S0033291799001269.
  • Li Q, Wang Y, Zhang Y, Li W, Zhu J, Zheng Y, Chen J, Zhao L, Zhou Z, Liu Y, et al. Assessing cue-induced brain response as a function of abstinence duration in heroin-dependent individuals: an event-related fMRI study. PLoS One. 2013;8:e62911. doi:10.1371/journal.pone.0062911.
  • Scott TM, Arnsten J, Olsen JP, Arias F, Cunningham CO, Rivera Mindt M. Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs. Addict Sci Clin Pract. 2021;16:64. doi:10.1186/s13722-021-00272-4.
  • Kalivas PW, Volkow N, Seamans J. Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron. 2005;45:647–50. doi:10.1016/j.neuron.2005.02.005.
  • Hu Y, Salmeron BJ, Gu H, Stein EA, Yang Y. Impaired functional connectivity within and between frontostriatal circuits and its association with compulsive drug use and trait impulsivity in cocaine addiction. JAMA Psychiatry. 2015;72:584–92. doi:10.1001/jamapsychiatry.2015.1.
  • Tolomeo S, Gray S, Matthews K, Steele JD, Baldacchino A. Multifaceted impairments in impulsivity and brain structural abnormalities in opioid dependence and abstinence. Psychol Med. 2016;46:2841–53. doi:10.1017/S0033291716001513.
  • Seifert CL, Magon S, Sprenger T, Lang UE, Huber CG, Denier N, Vogel M, Schmidt A, Radue E-W, Borgwardt S, et al. Reduced volume of the nucleus accumbens in heroin addiction. Eur Arch Psychiatry Clin Neurosci. 2015;265:637–45. doi:10.1007/s00406-014-0564-y.
  • Volkow ND, Morales M. The brain on drugs: from reward to addiction. Cell. 2015;162:712–25. doi:10.1016/j.cell.2015.07.046.
  • Shi Z, Jagannathan K, Padley JH, Wang AL, Fairchild VP, O’Brien CP, Childress AR, Langleben DD. The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder. Addict Biol. 2021;26:e12977. doi:10.1111/adb.12977.
  • Tanabe J, Tregellas JR, Dalwani M, Thompson L, Owens E, Crowley T, Banich M. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry. 2009;65:160–64. doi:10.1016/j.biopsych.2008.07.030.
  • Yang Z, Zhang Y, Cheng J, Zheng R. Meta-analysis of brain gray matter changes in chronic smokers. Eur J Radiol. 2020;132:109300. doi:10.1016/j.ejrad.2020.109300.
  • Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, da Costa MS, Mestriner R, Weis SN, Netto CA. Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull. 2012;87:109–16. doi:10.1016/j.brainresbull.2011.10.006.
  • Denier N, Gerber H, Vogel M, Klarhöfer M, Riecher-Rossler A, Wiesbeck GA, Lang UE, Borgwardt S, Walter M. Reduction in cerebral perfusion after heroin administration: a resting state arterial spin labeling study. PLoS One. 2013;8:e71461. doi:10.1371/journal.pone.0071461.
  • Denier N, Schmidt A, Gerber H, Schmid O, Riecher-Rössler A, Wiesbeck GA, Huber CG, Lang UE, Radue E-W, Walter M, et al. Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study. Front Psychiatry. 2013;4:135.
  • Rogers RL, Meyer JS, Shaw TG, Mortel KF, Hardenberg JP, Zaid RR. Cigarette smoking decreases cerebral blood flow suggesting increased risk for stroke. JAMA. 1983;250:2796–800. doi:10.1001/jama.1983.03340200030024.
  • Durazzo TC, Meyerhoff DJ, Murray DE. Comparison of regional brain perfusion levels in chronically smoking and non-smoking adults. Int J Env Res Public Health. 2015;12:8198–213. doi:10.3390/ijerph120708198.
  • Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology. 2010;210:453–69. doi:10.1007/s00213-010-1848-1.
  • Chamberlain SR, Odlaug BL, Schreiber LR, Grant JE. Association between tobacco smoking and cognitive functioning in young adults. Am J Addict. 2012;21 Suppl 1:S14–9. doi:10.1111/j.1521-0391.2012.00290.x.
  • Bava S, Tapert SF. Adolescent brain development and the risk for alcohol and other drug problems. Neuropsychol Rev. 2010;20:398–413. doi:10.1007/s11065-010-9146-6.
  • Wang X, Li B, Zhou X, Liao Y, Tang J, Liu T, Hu D, Hao W. Changes in brain gray matter in abstinent heroin addicts. Drug Alcohol Depend. 2012;126:304–08. doi:10.1016/j.drugalcdep.2012.05.030.
  • Hartwell ML, Croff JM, Morris AS, Breslin FJ, Dunn K. Association of prenatal opioid exposure with precentral gyrus volume in children. JAMA Pediatr. 2020;174:893–96. doi:10.1001/jamapediatrics.2020.0937.
  • Ye Y, Zhang J, Huang B, Cai X, Wang P, Zeng P, Wu S, Ma J, Huang H, Liu H, et al. Characterizing the structural pattern of heavy smokers using multivoxel pattern analysis. Front Psychiatry. 2020;11:607003.
  • Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86:1119–27. doi:10.1111/j.1360-0443.1991.tb01879.x.
  • Chang CM, Edwards SH, Arab A, Del Valle-Pinero AY Yang L, Hatsukami DK. Biomarkers of tobacco exposure: summary of an FDA-sponsored public workshop. Cancer Epidemiol Biomarkers Prev. 2017;26:291–302. doi:10.1158/1055-9965.EPI-16-0675.
  • Oliver JA, Foulds J. Association between cigarette smoking frequency and tobacco use disorder in US adults. Am J Prev Med. 2021;60:726–28. doi:10.1016/j.amepre.2020.10.019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.